4/A//SEC Filing
Jaffe Matthias 4/A
Accession 0000899243-18-027379
CIK 0001664106other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 5:03 PM ET
Size
5.8 KB
Accession
0000899243-18-027379
Insider Transaction Report
Form 4/AAmended
Jaffe Matthias
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-10-18+69,500→ 69,500 totalExercise: $10.00Exp: 2028-10-17→ Common Stock (69,500 underlying)
Footnotes (2)
- [F1]The option becomes exercisable in equal one forty-eighth installments from the vesting commencement date, October 18, 2018.
- [F2]The Form 4, as originally filed, incorrectly reported the number of derivative securities acquired, the amount of underlying securities and the number of derivative securities beneficially owned. The Form 4, as amended by this Form 4/A, correctly reports such information.
Documents
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001752457
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 5:03 PM ET
- Size
- 5.8 KB